The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (pembro) in combination with gemcitabine (Gem) and concurrent hypofractionated radiation therapy (RT) as bladder sparing treatment for muscle-invasive urothelial cancer of the bladder (MIBC): A multicenter phase 2 trial.
 
Arjun Vasant Balar
Honoraria - AstraZeneca/MedImmune; Genentech/Roche; Merck
Consulting or Advisory Role - AstraZeneca/MedImmune; Cerulean Pharma; Dragonfly Therapeutics; Genentech/Roche; GlaxoSmithKline; Incyte; Merck; Nektar; Pfizer/EMD Serono; Seattle Genetics/Astellas
Research Funding - AstraZeneca/MedImmune (Inst); Genentech/Roche (Inst); Merck (Inst); Seattle Genetics
 
Matthew I. Milowsky
Research Funding - Amgen (Inst); Arvinas (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Constellation Pharmaceuticals (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); Johnson & Johnson/Janssen (Inst); Merck (Inst); Mirati Therapeutics (Inst); Pfizer (Inst); Regeneron (Inst); Roche/Genentech (Inst); Seagen (Inst); Syndax (Inst)
 
Peter H. O'Donnell
Stock and Other Ownership Interests - allergan
Honoraria - Astellas Pharma; Atheneum; CLD, Inc.; Dedham Group; FirstWord; Genentech/Roche; Health Advances; Janssen; Merck; Pfizer; Schlesinger Associates; Seattle Genetics
Consulting or Advisory Role - Merck
Research Funding - Acerta Pharma (Inst); Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Janssen (Inst); Merck (Inst); Seattle Genetics (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Janssen; Janssen; Merck; Seattle Genetics/Astellas
Other Relationship - Dragonfly Therapeutics; Janssen; Nektar; NIH
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; BMS; Merck; Pfizer
Research Funding - Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Harpoon Therapeutics (Inst); Janssen (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Progenics (Inst); Progenics (Inst); Prometheus (Inst); Roche (Inst)
Travel, Accommodations, Expenses - BMS; Merck
 
Marisa Kollmeier
No Relationships to Disclose
 
Tracy L Rose
Research Funding - Bristol-Myers Squibb; GeneCentric; Merck; Roche/Genentech; X4 Pharmaceuticals
 
Sean Pitroda
No Relationships to Disclose
 
Samuel D. Kaffenberger
Consulting or Advisory Role - clovis oncology; MDxHealth
Travel, Accommodations, Expenses - BMS
 
Jonathan E. Rosenberg
Stock and Other Ownership Interests - Illumina
Honoraria - Clinical Care Options; ClinicalMind; Intellisphere; Medscape; Peerview; Physicans' Education Resource; Research To Practice; UpToDate
Consulting or Advisory Role - Adicet Bio; Astellas Pharma; AstraZeneca/MedImmune; Bayer; BioClin Therapeutics; Boehringer Ingelheim; Bristol-Myers Squibb; Fortress Biotech; GlaxoSmithKline; Immunomedics; Janssen Oncology; Lilly; Merck; Mirati Therapeutics; Pfizer/EMD Serono; Pharmacyclics; QED Therapeutics; Roche/Genentech; Seattle Genetics; western oncolytics
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech/Roche (Inst); QED Therapeutics (Inst); Seattle Genetics (Inst)
Patents, Royalties, Other Intellectual Property - Predictor of platinum sensitivity (Inst)
 
Kaitlyn Francese
Consulting or Advisory Role - Seattle Genetics
 
Tsivia Hochman
No Relationships to Disclose
 
Judith D Goldberg
Leadership - Statistical Science and Technology Associates Incorporated
Stock and Other Ownership Interests - Statistical Science and Technology Associates Incorporated
Consulting or Advisory Role - Amadix; Statistical Science and Technology Associates Incorporated
 
Sarah Griglun
No Relationships to Disclose
 
Dayna Leis
Consulting or Advisory Role - Seattle Genetics
 
Gary D. Steinberg
Stock and Other Ownership Interests - Epivax Therapeutics; Urogen pharma
Honoraria - Aduro Biotech; AstraZeneca; Bristol-Myers Squibb; CG Oncology; enGene; Epivax Oncology; fergene; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Janssen Oncology; MDxHealth; Merck; Pfizer; Photocure; Roche/Genentech; Seagen; Sesen Bio; Urogen pharma
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Natera; photocure; Roche/Genentech; Taris BioMedical
 
James Wysock
Honoraria - Intuitive Surgical
Consulting or Advisory Role - Intuitive Surgical
Travel, Accommodations, Expenses - Intuitive Surgical
 
Peter B. Schiff
No Relationships to Disclose
 
Nicholas J. Sanfilippo
Stock and Other Ownership Interests - Oncodisc
 
Samir Taneja
Stock and Other Ownership Interests - Abbvie; Gilead Sciences; Johnson & Johnson; Trod Medical
Consulting or Advisory Role - Exact Imaging; Francis Medical; InSightec; Janssen; Trod Medical
Research Funding - MDxHealth
Travel, Accommodations, Expenses - Trod Medical
 
William C. Huang
Consulting or Advisory Role - Intuitive Surgical
Research Funding - photocure; SonaCare Medical; Storz; Storz
Travel, Accommodations, Expenses - Photocure